epigallocatechin gallate has been researched along with Choriocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Genç, H; Sinan Özalp, S; Tansu Koparal, A; Tasa, BA; Telli, E | 1 |
| Kao, YH; Lin, CK; Lin, YR; Liu, HS; Shih, LJ | 1 |
2 other study(ies) available for epigallocatechin gallate and Choriocarcinoma
| Article | Year |
|---|---|
In vitro evaluation of combination of EGCG and Erlotinib with classical chemotherapeutics on JAR cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Catechin; Cell Line, Tumor; Choriocarcinoma; Dactinomycin; Enzyme Activation; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Receptor, ErbB-2; RNA, Messenger | 2017 |
Green tea (-)-epigallocatechin gallate induced growth inhibition of human placental choriocarcinoma cells.
Topics: AMP-Activated Protein Kinases; Antimitotic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Choriocarcinoma; Extracellular Signal-Regulated MAP Kinases; Female; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pregnancy; Tea; Uterine Neoplasms | 2016 |